ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $3.06M rose 1951.6% year over year, ahead of the +831.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 226.4% from the prior quarter. Over 3 fiscal years it compounded at +197.6% a year.
Context
- Depreciation & amortization amounted to 8.0% of revenue in FY2025, down 11375981.4 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1951.6% holds above the trailing-twelve-month pace of +831.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.91M USD
- Year-over-year change
- -100.0%
- 4-year CAGR
- +215.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.91M | -100.0% |
| FY2024 | 2024-12-31 | 471.42B | +1259372646.0% |
| FY2023 | 2023-12-31 | 37.43K | -48.4% |
| FY2022 | 2022-12-31 | 72.57K | +274.5% |
| FY2021 | 2021-12-31 | 19.38K | — |
Depreciation & Amortization vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +831.9% is the highest of 11, against a peer median of +8.3%.
- Depreciation & amortization amounts to 17.9% of revenue for ASPI, versus a peer median of 5.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$4.65B BRL | -7.3% | -1.1% | 7.0% | |
| LTM Mar 2026 | $311M USD | +7.6% | -89.2% | 10.7% | |
| LTM Mar 2026 | $135.21M USD | +21.8% | +1.9% | 11.0% | |
| LTM Mar 2026 | $129.72M USD | +13.9% | +10.0% | 5.5% | |
| LTM Mar 2026 | $104.5M USD | -1.4% | -2.9% | 8.1% | |
| LTM Mar 2026 | $99.68M USD | +9.0% | +2.0% | 5.1% | |
| LTM Mar 2026 | $84.03M USD | +13.1% | +1.4% | 6.1% | |
| LTM Apr 2026 | $22.84M USD | +3.6% | +17.8% | 4.7% | |
| LTM Mar 2026 | $6.02M USD | +26.8% | -7.8% | 4.5% | |
| LTM Mar 2026 | $4.82M USD | +831.9% | +197.6% | 17.9% | |
| LTM Mar 2026 | $1.37M USD | +5.3% | +8.7% | 3.5% | |
| Peer median (excluding ASPI) | — | +8.3% | +1.6% | 5.8% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.